Stay updated on Archway Study: PDS vs Monthly Ranibizumab in Wet AMD Clinical Trial
Sign up to get notified when there's something new on the Archway Study: PDS vs Monthly Ranibizumab in Wet AMD Clinical Trial page.

Latest updates to the Archway Study: PDS vs Monthly Ranibizumab in Wet AMD Clinical Trial page
- CheckyesterdayChange DetectedThe clinical trial page now presents the study record for the completed Archway trial, including its treatment comparison, participant criteria, outcome measures, and supporting documents.SummaryDifference88%

- Check8 days agoChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0, while the page continues to display a 403 error.SummaryDifference0.2%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedA sitewide NIH banner announces a terminology transition from “Artificial Intelligence” to “Super Intelligence,” and the site revision changes from v3.7.1 to v3.7.2. The study page continues to display a 403 error.SummaryDifference1%

- Check36 days agoChange DetectedThe footer displays site revision v3.7.1 instead of v3.7.0, while the page continues to show a 403 error.SummaryDifference0.2%

- Check50 days agoChange DetectedThe page now displays a 403 Forbidden error screen, replacing the study record content with a standard error page.SummaryDifference18%

- Check57 days agoChange DetectedRevision: v3.7.0 was added to the page, replacing the previous Revision: v3.6.6. This update reflects a version upgrade and does not alter the study details or other visible content.SummaryDifference0.0%

Stay in the know with updates to Archway Study: PDS vs Monthly Ranibizumab in Wet AMD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Archway Study: PDS vs Monthly Ranibizumab in Wet AMD Clinical Trial page.